James Benjamin Gleason1, Krunal B Patel2, Felix Hernandez2, Anas Hadeh2, Kristin B Highland3, Franck Rahaghi2, Jinesh P Mehta2. 1. Department of Pulmonary and Critical Care Medicine, Cleveand Clinic Florida, 2950 Cleveland Clinic Boulevard, Weston, FL, 33331, USA. gleasoj@ccf.org. 2. Department of Pulmonary and Critical Care Medicine, Cleveand Clinic Florida, 2950 Cleveland Clinic Boulevard, Weston, FL, 33331, USA. 3. Department of Pulmonary and Critical Care Medicine, Cleveland Clinic, 9500 Euclid Avenue, Desk A90, Cleveland, OH, 44195, USA.
Abstract
BACKGROUND: Systemic sclerosis is a chronic debilitating autoimmune disease characterized by endothelial dysfunction and multi-organ fibrosis. Interstitial lung disease, a common manifestation of SSc, is termed scleroderma-related interstitial lung disease (SSc-ILD) and along with pulmonary hypertension contributes to a majority of deaths in SSc. SSc-ILD patients frequently develop pulmonary hypertension, which prognosticates a poorer outcome. We investigated pulmonary artery dimensions as an outcome predictor in patients with SSc-ILD. METHODS: A retrospective chart review abstracting data from SSc-ILD patients evaluated at a large tertiary care center was performed. HRCT imaging was reviewed and pulmonary artery (PA) and ascending aorta (Ao) diameters were measured for calculation of the PA:Ao ratio. Additionally, demographics, vital signs, spirometric parameters, comorbidities, and mean pulmonary artery pressures were collected when available. Outcome analysis with lung transplant or death events within 4 years based on pulmonary artery size as well as PA:Ao ratio was performed. RESULTS: 70 SSc-ILD patients were identified. Mean pulmonary artery diameter and PA:Ao ratio was 31.17 and 1.07 mm, respectively. Patients with a pulmonary artery diameter ≥32 mm had higher risk of lung transplantation or death (p < 0.001) within 4 years. Patients with a PA:Ao ratio ≥1.1 also had higher risk of lung transplantation or death (p < 0.001) within 4 years. Unadjusted outcomes analyses also identified PA:Ao ratio ≥1.1 as an independent outcome predictor (hazard ratio 3.30, p < 0.001). CONCLUSIONS/CLINICAL IMPLICATIONS: In SSc-ILD patients, a PA:Ao ratio ≥1.1 is associated with higher risk of lung transplant or death. These data suggest that PA:Ao dimension may be used for prognostication in SSc-ILD.
BACKGROUND: Systemic sclerosis is a chronic debilitating autoimmune disease characterized by endothelial dysfunction and multi-organ fibrosis. Interstitial lung disease, a common manifestation of SSc, is termed scleroderma-related interstitial lung disease (SSc-ILD) and along with pulmonary hypertension contributes to a majority of deaths in SSc. SSc-ILDpatients frequently develop pulmonary hypertension, which prognosticates a poorer outcome. We investigated pulmonary artery dimensions as an outcome predictor in patients with SSc-ILD. METHODS: A retrospective chart review abstracting data from SSc-ILDpatients evaluated at a large tertiary care center was performed. HRCT imaging was reviewed and pulmonary artery (PA) and ascending aorta (Ao) diameters were measured for calculation of the PA:Ao ratio. Additionally, demographics, vital signs, spirometric parameters, comorbidities, and mean pulmonary artery pressures were collected when available. Outcome analysis with lung transplant or death events within 4 years based on pulmonary artery size as well as PA:Ao ratio was performed. RESULTS: 70 SSc-ILDpatients were identified. Mean pulmonary artery diameter and PA:Ao ratio was 31.17 and 1.07 mm, respectively. Patients with a pulmonary artery diameter ≥32 mm had higher risk of lung transplantation or death (p < 0.001) within 4 years. Patients with a PA:Ao ratio ≥1.1 also had higher risk of lung transplantation or death (p < 0.001) within 4 years. Unadjusted outcomes analyses also identified PA:Ao ratio ≥1.1 as an independent outcome predictor (hazard ratio 3.30, p < 0.001). CONCLUSIONS/CLINICAL IMPLICATIONS: In SSc-ILDpatients, a PA:Ao ratio ≥1.1 is associated with higher risk of lung transplant or death. These data suggest that PA:Ao dimension may be used for prognostication in SSc-ILD.
Authors: Micah R Fisher; Stephen C Mathai; Hunter C Champion; Reda E Girgis; Traci Housten-Harris; Laura Hummers; Jerry A Krishnan; Fredrick Wigley; Paul M Hassoun Journal: Arthritis Rheum Date: 2006-09
Authors: Esam H Alhamad; Ahmad A Al-Boukai; Feisal A Al-Kassimi; Hussam F Alfaleh; Mostafa Q Alshamiri; Abdulaziz H Alzeer; Hadil A Al-Otair; Gehan F Ibrahim; Shaffi A Shaik Journal: Radiology Date: 2011-05-25 Impact factor: 11.105
Authors: Wander O Villalba; Percival D Sampaio-Barros; Mônica C Pereira; Elza M F P Cerqueira; Cid A Leme; João F Marques-Neto; Ilma A Paschoal Journal: Chest Date: 2007-01 Impact factor: 9.410
Authors: Robert K McCall; James G Ravenel; Paul J Nietert; Aleksandra Granath; Richard M Silver Journal: J Comput Assist Tomogr Date: 2014 Mar-Apr Impact factor: 1.826
Authors: Irene M Lang; Christina Plank; Roela Sadushi-Kolici; Johannes Jakowitsch; Walter Klepetko; Gerald Maurer Journal: JACC Cardiovasc Imaging Date: 2010-12
Authors: A Fischer; J J Swigris; M B Bolster; L Chung; M E Csuka; R Domsic; T Frech; M Hinchcliff; V Hsu; L K Hummers; M Gomberg-Maitland; S C Mathai; R Simms; V D Steen Journal: Clin Exp Rheumatol Date: 2014-11-04 Impact factor: 4.473
Authors: Lorinda Chung; Robyn T Domsic; Bharathi Lingala; Firas Alkassab; Marcy Bolster; M E Csuka; Chris Derk; Aryeh Fischer; Tracy Frech; Daniel E Furst; Mardi Gomberg-Maitland; Monique Hinchcliff; Vivien Hsu; Laura K Hummers; Dinesh Khanna; Thomas A Medsger; Jerry A Molitor; Ioana R Preston; Elena Schiopu; Lee Shapiro; Richard Silver; Robert Simms; John Varga; Jessica K Gordon; Virginia D Steen Journal: Arthritis Care Res (Hoboken) Date: 2014-03 Impact factor: 5.178
Authors: Panja M Boehm; Stefan Schwarz; Jürgen Thanner; Cecilia Veraar; Mario Gerges; Christian Gerges; Irene Lang; Paul Apfaltrer; Helmut Prosch; Shahrokh Taghavi; Walter Klepetko; Hendrik Jan Ankersmit; Bernhard Moser Journal: JTCVS Open Date: 2022-02-23